Table 2.
Baseline ultrasound grading and fibrosis scores
| Variable | Control (32) | Orlistat (45) | P-value |
|---|---|---|---|
| US grades | 1.78±0.71 | 2.02±0.73 | 0.14 |
| 0 | 0 | 0 | |
| 1 | 12 (37.5) | 11 (24.44) | |
| 2 | 15 (46.87) | 22 (48.89) | |
| 3 | 6 (15.62) | 12 (26.67) | |
| NFS score | 1.25±0.44 | 1.22±0.42 | 0.78 |
| Low | 24 (75) | 35 (77.78) | |
| Intermediate | 8 (25) | 10 (22.22) | |
| High | 0 | 0 | |
| BARD score | 0.91±0.99 | 1.20±0.84 | 0.052 |
| Low | 26 (81.25) | 38 (84.44) | |
| High | 6 (18.75) | 7 (22.22) |
Note: Data are expressed as n (%).
Abbreviations: BARD, body mass index plus AST/ALT ratio plus presence of diabetes; NAFLD, nonalcoholic fatty liver disease; NFS, NAFLD fibrosis score; US, ultrasound.